156 related articles for article (PubMed ID: 26425554)
1. iTRAQ-Based Quantitative Proteomic Analysis Identified HSC71 as a Novel Serum Biomarker for Renal Cell Carcinoma.
Zhang Y; Cai Y; Yu H; Li H
Biomed Res Int; 2015; 2015():802153. PubMed ID: 26425554
[TBL] [Abstract][Full Text] [Related]
2. Quantitative proteomic analysis reveals potential diagnostic markers and pathways involved in pathogenesis of renal cell carcinoma.
White NM; Masui O; Desouza LV; Krakovska O; Metias S; Romaschin AD; Honey RJ; Stewart R; Pace K; Lee J; Jewett MA; Bjarnason GA; Siu KW; Yousef GM
Oncotarget; 2014 Jan; 5(2):506-18. PubMed ID: 24504108
[TBL] [Abstract][Full Text] [Related]
3. iTRAQ-based quantitative proteomic analysis reveals potential early diagnostic markers of clear-cell Renal cell carcinoma.
Zhang L; Jiang H; Xu G; Chu N; Xu N; Wen H; Gu B; Liu J; Mao S; Na R; Jing Y; Ding Q; Zhang Y; Wang L
Biosci Trends; 2016 Jul; 10(3):210-9. PubMed ID: 27319973
[TBL] [Abstract][Full Text] [Related]
4. Alterations of the serum peptidome in renal cell carcinoma discriminating benign and malignant kidney tumors.
Gianazza E; Chinello C; Mainini V; Cazzaniga M; Squeo V; Albo G; Signorini S; Di Pierro SS; Ferrero S; Nicolardi S; van der Burgt YE; Deelder AM; Magni F
J Proteomics; 2012 Dec; 76 Spec No.():125-40. PubMed ID: 22868251
[TBL] [Abstract][Full Text] [Related]
5. Proteins S100A8 and S100A9 are potential biomarkers for renal cell carcinoma in the early stages: results from a proteomic study integrated with bioinformatics analysis.
Zhang L; Jiang H; Xu G; Wen H; Gu B; Liu J; Mao S; Na R; Jing Y; Ding Q; Zhang Y
Mol Med Rep; 2015 Jun; 11(6):4093-100. PubMed ID: 25673070
[TBL] [Abstract][Full Text] [Related]
6. The predictive and prognostic values of serum amino acid levels for clear cell renal cell carcinoma.
Zhang F; Ma X; Li H; Guo G; Li P; Li H; Gu L; Li X; Chen L; Zhang X
Urol Oncol; 2017 Jun; 35(6):392-400. PubMed ID: 28188089
[TBL] [Abstract][Full Text] [Related]
7. Identification of potential serum proteomic biomarkers for clear cell renal cell carcinoma.
Yang J; Yang J; Gao Y; Zhao L; Liu L; Qin Y; Wang X; Song T; Huang C
PLoS One; 2014; 9(11):e111364. PubMed ID: 25368985
[TBL] [Abstract][Full Text] [Related]
8. 14-3-3 protein beta/alpha as a urinary biomarker for renal cell carcinoma: proteomic analysis of cyst fluid.
Minamida S; Iwamura M; Kodera Y; Kawashima Y; Tabata K; Matsumoto K; Fujita T; Satoh T; Maeda T; Baba S
Anal Bioanal Chem; 2011 Jul; 401(1):245-52. PubMed ID: 21553213
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Urine Aquaporin-1 and Perilipin-2 Concentrations as Biomarkers to Screen for Renal Cell Carcinoma: A Prospective Cohort Study.
Morrissey JJ; Mellnick VM; Luo J; Siegel MJ; Figenshau RS; Bhayani S; Kharasch ED
JAMA Oncol; 2015 May; 1(2):204-12. PubMed ID: 26181025
[TBL] [Abstract][Full Text] [Related]
10. Use of quantitative shotgun proteomics to identify fibronectin 1 as a potential plasma biomarker for clear cell carcinoma of the kidney.
Yokomizo A; Takakura M; Kanai Y; Sakuma T; Matsubara J; Honda K; Naito S; Yamada T; Ono M
Cancer Biomark; 2011-2012; 10(3-4):175-83. PubMed ID: 22674303
[TBL] [Abstract][Full Text] [Related]
11. Serum level of ANGPTL4 as a potential biomarker in renal cell carcinoma.
Dong D; Jia L; Zhou Y; Ren L; Li J; Zhang J
Urol Oncol; 2017 May; 35(5):279-285. PubMed ID: 28110976
[TBL] [Abstract][Full Text] [Related]
12. Reduced cytosolic carboxypeptidase 6 (CCP6) level leads to accumulation of serum polyglutamylated DNAJC7 protein: A potential biomarker for renal cell carcinoma early detection.
Li C; Wang J; Hao J; Dong B; Li Y; Zhu X; Ding J; Ren S; Zhao H; Wu S; Tian Y; Wang GQ
Oncotarget; 2016 Apr; 7(16):22385-96. PubMed ID: 26993597
[TBL] [Abstract][Full Text] [Related]
13. Application of SELDI-TOF-MS to identify serum biomarkers for renal cell carcinoma.
Xu G; Xiang CQ; Lu Y; Kang XN; Liao P; Ding Q; Zhang YF
Cancer Lett; 2009 Sep; 282(2):205-13. PubMed ID: 19362769
[TBL] [Abstract][Full Text] [Related]
14. Combination of MiR-378 and MiR-210 Serum Levels Enables Sensitive Detection of Renal Cell Carcinoma.
Fedorko M; Stanik M; Iliev R; Redova-Lojova M; Machackova T; Svoboda M; Pacik D; Dolezel J; Slaby O
Int J Mol Sci; 2015 Sep; 16(10):23382-9. PubMed ID: 26426010
[TBL] [Abstract][Full Text] [Related]
15. SELDI-TOF-MS-based serum proteomic screening in combination with CT scan distinguishes renal cell carcinoma from benign renal tumors and healthy persons.
Xu G; Xiang CQ; Lu Y; Wang WJ; Kang XN; Liao P; Ding Q; Zhang YF
Technol Cancer Res Treat; 2009 Jun; 8(3):225-30. PubMed ID: 19445540
[TBL] [Abstract][Full Text] [Related]
16. Liquid chromatography-mass spectrometry based serum peptidomic approach for renal clear cell carcinoma diagnosis.
Huang Z; Zhang S; Hang W; Chen Y; Zheng J; Li W; Xing J; Zhang J; Zhu E; Yan X
J Pharm Biomed Anal; 2014 Nov; 100():175-183. PubMed ID: 25168216
[TBL] [Abstract][Full Text] [Related]
17. Elevated serum-circulating RNA in patients with conventional renal cell cancer.
Feng G; Li G; Gentil-Perret A; Tostain J; Genin C
Anticancer Res; 2008; 28(1A):321-6. PubMed ID: 18383864
[TBL] [Abstract][Full Text] [Related]
18. Increased level of serum leucine-rich-alpha-2-glycoprotein 1 in patients with clear cell renal cell carcinoma.
Nakanishi S; Goya M; Suda T; Yonamine T; Sugawa A; Saito S
BMC Urol; 2024 Apr; 24(1):94. PubMed ID: 38658967
[TBL] [Abstract][Full Text] [Related]
19. Prolyl hydroxylase-3 is a novel renal cell carcinoma biomarker.
Kim KH; Lee HH; Yoon YE; Na JC; Kim KS; Han WK
Investig Clin Urol; 2019 Nov; 60(6):425-431. PubMed ID: 31692952
[TBL] [Abstract][Full Text] [Related]
20. Differential expression and clinical significance of serum protein among patients with clear-cell renal cell carcinoma.
Nuerrula Y; Rexiati M; Liu Q; Wang YJ
Cancer Biomark; 2015; 15(4):485-91. PubMed ID: 26406868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]